Global Nuclear Medicine & Radiopharmaceuticals Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Nuclear Medicine & Radiopharmaceuticals Market
Radiopharmaceuticals (also known as radioactive drugs) are drugs that contain radionuclides that emit radiation. The distribution of the radiopharmaceutical within the body is determined by the physiochemical properties of the drug, the stability of the radiolabel, the purity of the radiopharmaceutical preparation, the pathophysiologic state of the patient, and the presence or absence of interfering drugs. Dynamic and static images of the distribution of the radiopharmaceutical within the body can be obtained using a g-camera or another suitable instrument appropriate for the radiopharmaceutical being imaged—for example, positronemitting radiopharmaceuticals.

Due to the COVID-19 pandemic, the global Nuclear Medicine & Radiopharmaceuticals market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Diagnostic accounting for % of the Nuclear Medicine & Radiopharmaceuticals global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Oncology segment is altered to an % CAGR throughout this forecast period.

The major players in Chian Nuclear Medicine & Radiopharmaceuticals market include China Isotope & Radiation, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Beijing and Chengdu are main markets, they occupy about 65% of the whole market. Diagnostic is the main type, with a share about 80%. Cardiology is the main application, which holds a share about 40%.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Diagnostic

Therapeutic

Segment by Application

Oncology

Thyroid

Cardiology

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Nuclear Medicine & Radiopharmaceuticals market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

China Isotope & Radiation

Dongcheng

Jaco

Ciaeriar

Advanced Molecular-imaging Solution

Shanghai Atom Kexing

TABLE OF CONTENT

1 Study Coverage
1.1 Nuclear Medicine & Radiopharmaceuticals Product Introduction

1.2 Market by Type

1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Diagnostic

1.2.3 Therapeutic

1.3 Market by Application

1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Estimates and Forecasts 2017-2028

2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Estimates and Forecasts 2017-2028

2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region

2.4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2017-2022)

2.4.2 Global Sales Nuclear Medicine & Radiopharmaceuticals by Region (2023-2028)

2.5 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region

2.5.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2017-2022)

2.5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturers

3.1.1 Global Top Nuclear Medicine & Radiopharmaceuticals Manufacturers by Sales (2017-2022)

3.1.2 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nuclear Medicine & Radiopharmaceuticals in 2021

3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers

3.2.1 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturers (2017-2022)

3.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Nuclear Medicine & Radiopharmaceuticals Revenue in 2021

3.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Nuclear Medicine & Radiopharmaceuticals Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type

4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Historical Sales by Type (2017-2022)

4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Sales by Type (2023-2028)

4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2017-2028)

4.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type

4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Historical Revenue by Type (2017-2022)

4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Revenue by Type (2023-2028)

4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2017-2028)

4.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type

4.3.1 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2017-2022)

4.3.2 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Application

5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Historical Sales by Application (2017-2022)

5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Sales by Application (2023-2028)

5.1.3 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2017-2028)

5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application

5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Historical Revenue by Application (2017-2022)

5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Forecasted Revenue by Application (2023-2028)

5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2017-2028)

5.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application

5.3.1 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2017-2022)

5.3.2 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Application (2023-2028)

6 North America

6.1 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Type

6.1.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2028)

6.1.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2017-2028)

6.2 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Application

6.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2028)

6.2.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2017-2028)

6.3 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country

6.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2028)

6.3.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Type

7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2028)

7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2017-2028)

7.2 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Application

7.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2028)

7.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2017-2028)

7.3 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country

7.3.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2028)

7.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Type

8.1.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2028)

8.1.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2017-2028)

8.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Application

8.2.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2028)

8.2.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2017-2028)

8.3 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Region

8.3.1 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2017-2028)

8.3.2 Asia Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size by Type

9.1.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2028)

9.1.2 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2017-2028)

9.2 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size by Application

9.2.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2028)

9.2.2 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2017-2028)

9.3 Latin America Nuclear Medicine & Radiopharmaceuticals Market Size by Country

9.3.1 Latin America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2028)

9.3.2 Latin America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Type

10.1.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2017-2028)

10.1.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2017-2028)

10.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Application

10.2.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2017-2028)

10.2.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2017-2028)

10.3 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country

10.3.1 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2017-2028)

10.3.2 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 China Isotope & Radiation

11.1.1 China Isotope & Radiation Corporation Information

11.1.2 China Isotope & Radiation Overview

11.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 China Isotope & Radiation Recent Developments

11.2 Dongcheng

11.2.1 Dongcheng Corporation Information

11.2.2 Dongcheng Overview

11.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Dongcheng Recent Developments

11.3 Jaco

11.3.1 Jaco Corporation Information

11.3.2 Jaco Overview

11.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Jaco Recent Developments

11.4 Ciaeriar

11.4.1 Ciaeriar Corporation Information

11.4.2 Ciaeriar Overview

11.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Ciaeriar Recent Developments

11.5 Advanced Molecular-imaging Solution

11.5.1 Advanced Molecular-imaging Solution Corporation Information

11.5.2 Advanced Molecular-imaging Solution Overview

11.5.3 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Advanced Molecular-imaging Solution Nuclear Medicine & Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Advanced Molecular-imaging Solution Recent Developments

11.6 Shanghai Atom Kexing

11.6.1 Shanghai Atom Kexing Corporation Information

11.6.2 Shanghai Atom Kexing Overview

11.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Shanghai Atom Kexing Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Nuclear Medicine & Radiopharmaceuticals Industry Chain Analysis

12.2 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Nuclear Medicine & Radiopharmaceuticals Production Mode & Process

12.4 Nuclear Medicine & Radiopharmaceuticals Sales and Marketing

12.4.1 Nuclear Medicine & Radiopharmaceuticals Sales Channels

12.4.2 Nuclear Medicine & Radiopharmaceuticals Distributors

12.5 Nuclear Medicine & Radiopharmaceuticals Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Nuclear Medicine & Radiopharmaceuticals Industry Trends

13.2 Nuclear Medicine & Radiopharmaceuticals Market Drivers

13.3 Nuclear Medicine & Radiopharmaceuticals Market Challenges

13.4 Nuclear Medicine & Radiopharmaceuticals Market Restraints

14 Key Findings in The Global Nuclear Medicine & Radiopharmaceuticals Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample